Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2020International Journal of Surgery OpenOpen Access

Is routine dissection of central lymph node and radio-active iodine therapy, necessary for papillary thyroid carcinoma, T1-2 N0? A randomized controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBassem SiedaZagazig UniversityMTMohamed Mohamed TawfikBeni-Suef UniversityHKHeba Khatur

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sieda et al. (2020) studied this question.

synapsesocial.com/papers/6a821794aedbb2834ec69eb7https://doi.org/10.1016/j.ijso.2020.05.002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation2015 · 40 citations
  2. 2Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual2017 · 376 citations
  3. 3Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes2017 · 45 citations
  4. 4Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma: Clinical Implications Derived From the First Prospective Randomized Controlled Single Institution Study2015 · 325 citations